ArticleJournal of clinical pharmacology2021

Evaluation of the Relationship of Glasdegib Exposure and Safety End Points in Patients With Refractory Solid Tumors and Hematologic Malignancies.

Ana Ruiz-Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.